Viral Pneumonia Clinical Trial
Official title:
Relevance of the Multiplex PCR Approach for Severe Respiratory Infections of Patients Hospitalized - Including an Intensive Care Unit, During the COVID-19 Pandemic
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge.
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge: - the main goal was to perform a retrospective investigation of the molecular virological tests in a University hospital, in order to identify non-COVID-19 respiratory viruses from the beginning of 2021 to mid-2022 during the circulation of SARS-CoV-2, for public health knowledge; - the secondary aim was to retrospectively analyze, for a small subgroup of patients from an intensive care unit, the files of patients with positive molecular virological tests for non-COVID-19 respiratory viruses from the beginning of 2021 to mid-2022, reporting the following standard-of-care data: (i) the identification of the viruses, (ii) bioclinical features, (iii) medical impact of virological results in real life. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05286255 -
Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias
|
Phase 1 | |
| Recruiting |
NCT04952337 -
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
|
||
| Completed |
NCT04606407 -
Inhaled NO for the Treatment of Viral Pneumonia in Adults
|
N/A | |
| Not yet recruiting |
NCT05612893 -
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
|
||
| Not yet recruiting |
NCT04397497 -
Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
|
Phase 2 | |
| Terminated |
NCT04345289 -
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
|
Phase 3 | |
| Enrolling by invitation |
NCT04326036 -
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
|
Early Phase 1 | |
| Withdrawn |
NCT00645619 -
Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
|
||
| Completed |
NCT04385823 -
Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure
|
||
| Not yet recruiting |
NCT04876573 -
Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
|
Phase 2 | |
| Unknown status |
NCT01612572 -
A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
|
N/A | |
| Completed |
NCT02152358 -
PTH - Preemptive Treatment for Herpesviridae
|
Phase 4 | |
| Completed |
NCT04644302 -
Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
|
||
| Recruiting |
NCT05531149 -
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
|
Phase 3 | |
| Not yet recruiting |
NCT04955223 -
Yinhu Qingwen Granule in the Treatment of Viral Pneumonia
|
Early Phase 1 | |
| Completed |
NCT01868113 -
Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
|
Phase 3 | |
| Recruiting |
NCT04380376 -
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
|
Phase 2 | |
| Completed |
NCT05386459 -
Study of the Use of the Drug Ingaron in Patients With COVID-19
|
||
| Completed |
NCT04394026 -
Imaging Feature of SARS-CoV2 Infection
|
||
| Not yet recruiting |
NCT04820751 -
Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial
|
Phase 3 |